Medytoks was ranked among the top searched stocks on 2 days within the past month.


As of 2:30 PM on the 22nd, Medytoks is trading at 164,200 KRW, down 6.76% from the previous day. This represents a 31.55% decline compared to September 18. Medytoks is known as a manufacturer and seller of pharmaceuticals and cosmetic pharmaceuticals.

Today, foreigners have a tentative net sale of 12,000 shares of Medytoks, while institutions have a net purchase of 3,000 shares. Over the past 5 days, individual investors have net purchased 19,000 shares, whereas foreigners and institutions have net sold 8,965 shares and 17,333 shares, respectively.


On October 21, Medytoks became an issue in the market with the announcement of the 'Partner Parksin COVID-19 Vaccine Manufacturing and Commercialization Contract in Indonesia'↑...





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing